Back to DE Deerfield Management Company, L.P.

FUSNFUSN

10 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in FUSION PHARMACEUTICALS INC

As of its Q1 2024 13F, Deerfield Management held 6,401,000 shares of FUSN (Fusion Pharmaceuticals), worth $136.5M. Deerfield Management's 13F filings listed FUSN from Q1 2023 to Q1 2024, 5 quarterly filings. FUSN was 2.4% of Deerfield Management's reported 13F portfolio.

Final Value

$0

Final Shares

0

Total Value Change

-$22M

Total Shares Change

—

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Unchanged
6.4M
0.0%
$136.5M2.4%—
0
2023-Q4
Increased
6.4M
+126.7%
$61.5M1.1%—
75
2023-Q3
Unchanged
2.8M
0.0%
$7.3M0.2%—
0
2023-Q2
Unchanged
2.8M
0.0%
$13.2M0.3%—
0
2023-Q1
New
2.8M
—
$10.6M0.2%—
46
2021-Q1
Exited
0
-100.0%
$00.0%—
0
2020-Q4
Decreased
162,378
-83.3%
$1.9M0.0%—
0
2020-Q3
Decreased
972,046
-22.7%
$11.7M0.3%—
0
2020-Q2
New
1.3M
—
$22M0.6%—
56

Optional analytics helps us improve. How it’s used